Innovative healthcare: plans to repurchase shares worth 50 million to 100 million yuan to maintain company value.

The Innovative Medical Announcement stated that the company has decided to repurchase shares through centralized bidding with its own funds to maintain the company's value and shareholder rights. The total amount of the repurchase fund shall not be less than 50 million yuan and not exceed 100 million yuan, with a repurchase price not exceeding 20 yuan per share, and the implementation period shall be within 3 months from the date of approval of the plan by the board of directors. The repurchase of shares this time is expected to be 2.5 million to 5 million shares, accounting for approximately 0.57% to 1.13% of the total issued shares of the company. In addition, Director Ruan Guangyin had previously reduced his holdings by 80,000 shares, and major shareholders did not engage in insider trading or have any plans to reduce their holdings during the repurchase period. The repurchase this time carries risks such as funding and stock price fluctuations.